Indoco’s Baddi facility gets EU GMP certification from Health Authority of Germany

Our Bureau, Mumbai

Friday, June 9, 2023, 14:40 Hrs [IST]

Indoco Remedies has received EU GMP certification from the Competent Health Authority of Germany for its manufacturing site situated at HB 211 Village Katha, IN- 173 205 Baddi, Tehsil- Nalagarh, District - Solan. The Agency conducted an inspection at Indoco’s manufacturing facility for oral dosage form (Baddi -III), from May 22 - 25, 2023.

The EU GMP certification issued by the German Health Authority (Berlin) confirms that the site complies with the good manufacturing practice requirements as referred in the EC Directive. The EU certification will support supplies of drug products registered in Europe, from this manufacturing site.

Commenting on the development, Aditi Panandikar, managing director – Indoco Remedies Ltd., said that "The EU GMP certification for our site in Baddi adds to our consistent efforts to supply quality and affordable medicines in Europe. We are committed to being cGMP compliant and supplying quality products to our customers and patients across the globe."

Indoco is a fully integrated, research-oriented pharmaceutical company with presence in 55 countries. The company’s turnover is US$ 200 million with a human capital of 6,000 employees, including over 300 skilled scientists and field staff who are the strength of the organization.